FDA Inspection 904757 — Alfredo Gazca Aguilar, MD

Alfredo Gazca Aguilar, MD — FEI 3011026907

The FDA completed an inspection of Alfredo Gazca Aguilar, MD on November 21, 2014 in Zapopan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 21, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Zapopan (Mexico)

Additional Details

Clinical Investigator (CI)